Joe B. Blumer

Joe B. Blumer

Auto-generated profile, based on publicly available information

Joe B. Blumer

Department of Cell and Molecular Pharmacology and Experimental Therapeutics Medical University of South Carolina Charleston South Carolina USA

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2006 in Annual Review of Pharmacology and Toxicology
Verified
Journal Article
Closed access
MSMotohiko Sato
Motohiko Sato
JBJoe B. Blumer
Joe B. Blumer
VSViolaine Simon
Violaine Simon
SLStephen M. Lanier
Stephen M. Lanier
▪ Abstract Accessory proteins involved in signal processing through heterotrimeric G proteins are generally defined as proteins distinct from G protein–coupled receptor (GPCR), G protein, or classical effectors that regulate the strength/efficiency/specificity of signal transfer upon receptor activation or position these entities in the right microenvironment, contributing to the formation of a functional signal transduction complex. A flurry of recent studies have implicated an additional class of accessory proteins for this system that provide signal input to heterotrimeric G proteins in the absence of a cell surface receptor, serve as alternative binding partners for G protein subunits, provide unexpected modes of G protein regulation, and have introduced additional functional roles for G proteins. This group of accessory proteins includes the recently discovered Activators of G protein Signaling (AGS) proteins identified in a functional screen for receptor-independent activators of G protein signaling as well as several proteins identified in protein interaction screens and genetic screens in model organisms. These accessory proteins may influence GDP dissociation and nucleotide exchange at the Gα subunit, alter subunit interactions within heterotrimeric Gαβγ independent of nucleotide exchange, or form complexes with Gα or Gβγ independent of the typical Gαβγ heterotrimer. AGS and related accessory proteins reveal unexpected diversity in G protein subunits as signal transducers within the cell.

20 November 2005 in Nature Cell Biology
Verified
Journal Article
Closed access
NSNathalie Sans
Nathalie Sans
PWPhilip Y. Wang
Philip Y. Wang
QDQuansheng Du
Quansheng Du
RPRonald S. Petralia
Ronald S. Petralia
YWYa-Xian Wang
Ya-Xian Wang
RWRobert J. Wenthold
Robert J. Wenthold

1 March 2007 in Pharmacology & Therapeutics
Verified
Journal Article
Closed access
JBJoe B. Blumer
Joe B. Blumer
ASAlan V. Smrcka
Alan V. Smrcka
SLStephen M. Lanier
Stephen M. Lanier

1 May 2002 in Journal of Biological Chemistry
Verified
Journal Article
Open access
JBJoe B. Blumer
Joe B. Blumer
LCL. Judson Chandler
L. Judson Chandler
SLStephen M. Lanier
Stephen M. Lanier
Activator of G-protein signaling 3 (AGS3) and LGN have a similar domain structure and contain four G-protein regulatory motifs that serve as anchors for the binding of the GDP-bound conformation of specific G-protein alpha subunits. As an initial approach to define further the different functional roles of AGS3 and LGN, we determined their expression profile and subcellular distribution. AGS3- and LGN-specific antisera indicated a widespread tissue distribution of LGN, whereas AGS3 is primarily enriched in brain. Brain punch biopsies of 13 discrete brain regions indicated that both AGS3 and LGN are expressed in all areas tested but are differentially regulated during development. LGN is expressed in neuronal, astroglial, and microglial cultures, whereas AGS3 expression is restricted to neurons. In primary neuronal cultures as well as in dividing cultures of PC12 cells, immunocytochemistry indicated distinct subcellular locations of AGS3 and LGN. The subcellular locations of the two proteins were differentially regulated by external stimuli and the cell cycle. In PC12 and COS7 cells, LGN moves from the nucleus to the midbody structure separating daughter cells during the later stages of mitosis, suggesting a role for G-proteins in cytokinesis. Thus, although AGS3 and LGN share a similar overall motif structure and both bind G-proteins, nature has endowed these proteins with different regulatory elements that allow functional diversity by virtue of tissue-specific expression and subcellular positioning.

1 February 2013 in Journal of Biological Chemistry
Verified
Journal Article
Open access
SOSukru Sadik Oner
Sukru Sadik Oner
EMEllen M. Maher
Ellen M. Maher
MGMeital Gabay
Meital Gabay
GTGregory G. Tall
Gregory G. Tall
JBJoe B. Blumer
Joe B. Blumer
SLStephen M. Lanier
Stephen M. Lanier
Group II activators of G-protein signaling (AGS) serve as binding partners for Gα(i/o/t) via one or more G-protein regulatory (GPR) motifs. GPR-Gα signaling modules may be differentially regulated by cell surface receptors or by different nonreceptor guanine nucleotide exchange factors. We determined the effect of the nonreceptor guanine nucleotide exchange factors AGS1, GIV/Girdin, and Ric-8A on the interaction of two distinct GPR proteins, AGS3 and AGS4, with Gα(il) in the intact cell by bioluminescence resonance energy transfer (BRET) in human embryonic kidney 293 cells. AGS3-Rluc-Gα(i1)-YFP and AGS4-Rluc-Gα(i1)-YFP BRET were regulated by Ric-8A but not by Gα-interacting vesicle-associated protein (GIV) or AGS1. The Ric-8A regulation was biphasic and dependent upon the amount of Ric-8A and Gα(i1)-YFP. The inhibitory regulation of GPR-Gα(i1) BRET by Ric-8A was blocked by pertussis toxin. The enhancement of GPR-Gα(i1) BRET observed with Ric-8A was further augmented by pertussis toxin treatment. The regulation of GPR-Gα(i) interaction by Ric-8A was not altered by RGS4. AGS3-Rluc-Gα(i1)-YFP and AGS4-Rluc-G-Gα(i1)-YFP BRET were observed in both pellet and supernatant subcellular fractions and were regulated by Ric-8A in both fractions. The regulation of the GPR-Gα(i1) complex by Ric-8A, as well as the ability of Ric-8A to restore Gα expression in Ric8A(-/-) mouse embryonic stem cells, involved two helical domains at the carboxyl terminus of Ric-8A. These data indicate a dynamic interaction between GPR proteins, Gα(i1) and Ric-8A, in the cell that influences subcellular localization of the three proteins and regulates complex formation.

1 March 2014 in Molecular Pharmacology
Verified
Journal Article
Closed access
PDF file
JBJoe B. Blumer
Joe B. Blumer
SLStephen M. Lanier
Stephen M. Lanier
Activators of G protein signaling (AGS), initially discovered in the search for receptor-independent activators of G protein signaling, define a broad panel of biologic regulators that influence signal transfer from receptor to G-protein, guanine nucleotide binding and hydrolysis, G protein subunit interactions, and/or serve as alternative binding partners for Gα and Gβγ independently of the classic heterotrimeric Gαβγ. AGS proteins generally fall into three groups based upon their interaction with and regulation of G protein subunits: group I, guanine nucleotide exchange factors (GEF); group II, guanine nucleotide dissociation inhibitors; and group III, entities that bind to Gβγ. Group I AGS proteins can engage all subclasses of G proteins, whereas group II AGS proteins primarily engage the Gi/Go/transducin family of G proteins. A fourth group of AGS proteins with selectivity for Gα16 may be defined by the Mitf-Tfe family of transcription factors. Groups I–III may act in concert, generating a core signaling triad analogous to the core triad for heterotrimeric G proteins (GEF + G proteins + effector). These two core triads may function independently of each other or actually cross-integrate for additional signal processing. AGS proteins have broad functional roles, and their discovery has advanced new concepts in signal processing, cell and tissue biology, receptor pharmacology, and system adaptation, providing unexpected platforms for therapeutic and diagnostic development.